10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-039803`
Period End Date	20190930
Filing Date	20191104
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	nbix-10q_20190930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 77 Cash Flow Statement 64 Stockholders Equity 44

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$166.64M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.71M	USD	Point-in-time
Short-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$509.20M	USD	Point-in-time
Short-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$503.52M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$57.41M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$115.32M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Inventory	`InventoryNet`	$10.80M	USD	Point-in-time
Inventory	`InventoryNet`	$10.86M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	90.80M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	92.08M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$22.95M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$18.59M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	90.80M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	92.08M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$819.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$737.78M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.71M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.48M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$33.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$40.30M	USD	Point-in-time
Long-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesNoncurrent`	$204.79M	USD	Point-in-time
Long-term investments in available-for-sale debt securities	`AvailableForSaleSecuritiesNoncurrent`	$216.03M	USD	Point-in-time
Investment in restricted equity securities	`EquitySecuritiesFvNiRestricted`	$48.91M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$61.99M	USD	Point-in-time
Total assets	`Assets`	$1.18B	USD	Point-in-time
Total assets	`Assets`	$993.15M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$86.38M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$102.36M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.86M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$13.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.23M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$115.65M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$74.48M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$403.59M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$388.50M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.23M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$11.70M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$18.11M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$512.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$605.42M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000 shares authorized; issued and outstanding shares were 92,080 as of September 30, 2019 and 90,797 as of December 31, 2018	`CommonStockValue`	$91.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000 shares authorized; issued and outstanding shares were 92,080 as of September 30, 2019 and 90,797 as of December 31, 2018	`CommonStockValue`	$92.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.74B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.66B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.93M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.17B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.18B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$409.27M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$483.71M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$480.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$574.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$377.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$364.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$447.51M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.18B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$993.15M	USD	Point-in-time

Income Statement 77 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$151.76M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$319.75M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$222.09M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$544.08M	USD	3 Qtrs
Cost of sales	`CostOfSales`	$3.35M	USD	3 Qtrs
Cost of sales	`CostOfSales`	$2.23M	USD	1 Quarter
Cost of sales	`CostOfSales`	$1.55M	USD	1 Quarter
Cost of sales	`CostOfSales`	$4.97M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$144.62M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$35.48M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$45.28M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$121.42M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$118.08M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$84.49M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$179.95M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$252.85M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$520.51M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$97.43M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$132.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$304.72M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$54.32M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$90.10M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$15.02M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$23.56M	USD	3 Qtrs
Interest expense	`InterestExpense`	$8.04M	USD	1 Quarter
Interest expense	`InterestExpense`	$23.83M	USD	3 Qtrs
Interest expense	`InterestExpense`	$7.67M	USD	1 Quarter
Interest expense	`InterestExpense`	$22.77M	USD	3 Qtrs
Unrealized loss on restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-5.80M	USD	3 Qtrs
Unrealized loss on restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-28.45M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$10.78M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$4.80M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$13.98M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$4.11M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-31.69M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-3.56M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-15.66M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-11.99M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$50.76M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.90M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$58.41M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.03M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.89M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.62M	USD	1 Quarter
Net income	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.03M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$3.01M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$53.79M	USD	1 Quarter
Net income	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-206.00K	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$961.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.54M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$753.00K	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$6.55M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$51.52M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$54.75M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.83M	USD	3 Qtrs
Net income per share, basic	`EarningsPerShareBasic`	$0.59	USD	1 Quarter
Net income per share, basic	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Net income per share, basic	`EarningsPerShareBasic`	$0.03	USD	3 Qtrs
Net income per share, basic	`EarningsPerShareBasic`	$0.03	USD	3 Qtrs
Net income per share, diluted	`EarningsPerShareDiluted`	$0.03	USD	3 Qtrs
Net income per share, diluted	`EarningsPerShareDiluted`	$0.03	USD	3 Qtrs
Net income per share, diluted	`EarningsPerShareDiluted`	$0.52	USD	1 Quarter
Net income per share, diluted	`EarningsPerShareDiluted`	$0.56	USD	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.86M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.06M	shares	3 Qtrs
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.56M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.44M	shares	3 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.27M	shares	3 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.07M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.23M	shares	3 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.80M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.03M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$3.01M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$53.79M	USD	1 Quarter
Net income	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$44.80M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$53.95M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.36M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.75M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$13.04M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$14.06M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.04M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$989.00K	USD	3 Qtrs
Net (accretion of discounts) amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.44M	USD	3 Qtrs
Net (accretion of discounts) amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.47M	USD	3 Qtrs
Change in fair value of restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-5.80M	USD	3 Qtrs
Change in fair value of restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-28.45M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$-482.00K	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$792.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$57.91M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$23.44M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.91M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-66.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.71M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.18M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.34M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$15.58M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$14.64M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-175.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$49.50M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$50.91M	USD	3 Qtrs
Purchases of available-for-sale debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$329.29M	USD	3 Qtrs
Purchases of available-for-sale debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$467.09M	USD	3 Qtrs
Sales and maturities of available-for-sale debt securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$211.40M	USD	3 Qtrs
Sales and maturities of available-for-sale debt securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$488.82M	USD	3 Qtrs
Purchase of restricted equity securities	`PaymentsToAcquireRestrictedInvestments`	$54.72M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.80M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.94M	USD	3 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$8.00K	USD	3 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$30.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-136.66M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.91M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$20.03M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$27.75M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.03M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.75M	USD	3 Qtrs
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-58.00M	USD	3 Qtrs
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.61M	USD	3 Qtrs
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.81M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.81M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.21M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.82M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.82M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$507.00K	USD	3 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$55.00K	USD	3 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$1.80M	USD	3 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Begining balance	`StockholdersEquity`	$409.27M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$483.71M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$480.76M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$574.51M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$377.44M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$364.49M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$447.51M	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.03M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.01M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$53.79M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$888.00K	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$878.00K	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$961.00K	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.70M	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.85M	USD	1 Quarter
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$753.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.07M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.76M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.93M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.85M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.25M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.88M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.49M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.28M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.16M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.58M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.12M	USD	1 Quarter
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.14M	USD	1 Quarter
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.54M	USD	1 Quarter
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.65M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$409.27M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$483.71M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$480.76M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$574.51M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$377.44M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$364.49M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$447.51M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.